![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
BIO: Where Breakthroughs Begin | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
About BIO | BIO
BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of ...
BIO Events | BIO
Discover important industry trends. Identify crucial investment opportunities. Establish valuable professional partnerships. As the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and empower biotech innovators and their ecosystem to improve lives, but also ...
BIO International Convention
Jun 3, 2024 · Attend the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe! The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over…
BIO Applauds Introduction of Bipartisan ORPHAN Cures Act
6 days ago · Urges Congress to support rare disease patients & support the bill. WASHINGTON, D.C. (February 5, 2025) – John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), today released the following statement after introduction of the ORPHAN Cures Act (H.R. 946), a bipartisan bill that removes barriers to treating and curing rare disease:
BioSafe | BIO
Started in 2003, BioSafe is the Biotechnology Innovation Organization’s preclinical safety committee within BIO’s health section, comprised of >300 BIO members working to identify key scientific and regulatory issues and developments related to the preclinical safety evaluation of biopharmaceutical products and recommending appropriate science-based responses.
Become a BIO Member | BIO
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
Senior Leadership Team at BIO
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.
International | BIO
Building a strong biotechnology sector is a strategic priority and part of an increasing number of countries’ economic vision. Through a collaboration with the Pugatch Consilium, BIO helps governments understand the best ways to encourage innovation and attract investment.The report “Building the Bioeconomy” evaluates countries’ progress towards building their bioeconomies with a …